Consulting.

HEOR, RWE, and PRO Expertise

Our team brings expertise across health economics and outcomes research (HEOR), real-world evidence (RWE), patient-reported outcomes (PROs), market access and reimbursement, pricing, and artificial intelligence (AI).

Strategic HEOR and Market Access Solutions

We help clients navigate complex market access challenges with strategies that strengthen HCP and patient engagement and support optimal reimbursement, formulary placement, and market differentiation. Our consulting services include landscape assessments, strategic HEOR guidance, payer and health technology assessments (HTA) strategy, RWE generation, reimbursement and pricing advice, and PRO support and instrument selection for clinical trials.

Proven Results

With over 150 peer-reviewed publications, our research has been used in regulatory submissions, supported label expansions, and advanced FDAMA Section 114 claims. We have advised Fortune 100 companies on commercialization and access strategies across therapeutic areas, consistently driving measurable ROI and improved patient outcomes.

A Partner for Every Stage of the Product Lifecycle

Whether supporting commercial, medical affairs, and field sales teams, shaping evidence strategies, or guiding brand differentiation, we offer consulting solutions grounded in expertise and informed by the realities of care, helping clients achieve both business success and patient impact.